Physician profile
Batool Jafri
NPI 1053331538
$11,255.44
in general payments reported to CMS, 2019-2025
15 companies · $5,293 in 2025
The $5,293 reported for 2025 was more than what 93% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $324 · 2021: $224 · 2022: $142 · 2023: $4,623 · 2024: $210 · 2025: $5,293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,000 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,400 · Food and Beverage: $709 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,400.00 |
| Food and Beverage | $708.51 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $4,465.05 | 2021-2024 | Clareon |
| Rxsight INC | $3,663.08 | 2024-2025 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Tarsus Pharmaceuticals, INC. | $1,515.61 | 2024-2025 | Xdemvy |
| Allergan, INC. | $448.93 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $326.45 | 2020-2025 | Cequa |
| Novartis Pharmaceuticals Corporation | $213.00 | 2020-2023 | |
| Dompe US, INC. | $152.33 | 2021-2024 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $148.77 | 2019-2020 | |
| Oyster Point Pharma, INC. | $79.95 | 2022-2025 | Tyrvaya |
| Mallinckrodt Hospital Products INC. | $60.72 | 2021 | |
| Bausch & Lomb Americas INC. | $55.87 | 2025 | Miebo |
| Harrow Eye, LLC | $39.55 | 2025 | Vevye, Iheezo |
| Glaukos Corporation | $36.10 | 2020 | |
| Carl Zeiss Meditec USA, INC. | $31.81 | 2023 | Visumax |
| Abbvie INC. | $18.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Batool Jafri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.